| Allergan is a pharmaceutical company focused on developing, manufacturing and commercializing pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world. Co. has three segments: United States Specialized Therapeutics, which includes products within the United States, including Medical Aesthetics, Medical Dermatology Eye Care and Neuroscience and Urology therapeutic products; United States General Medicine, which includes products within the United States that do not fall into the United States Specialized Therapeutics business units, including Central Nervous System; and International, which includes products sold outside the United States. We show 26 historical shares outstanding datapoints in our coverage of AGN's shares outstanding history.|
Understanding the changing numbers of AGN shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like AGN versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching AGN by allowing them to research AGN shares outstanding history
as well as any other stock in our coverage universe.